BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31462626)

  • 21. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous follicle center lymphoma mimicking folliculitis.
    Chockalingam R; Aneja S; Patel AB
    Cutis; 2018 Jan; 101(1):E30-E33. PubMed ID: 29529119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse large B-cell lymphoma solely involving bilateral adrenal glands and stomach: report of an extremely rare case with review of the literature.
    Wakabayashi M; Sekiguchi Y; Shimada A; Ichikawa K; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(11):8190-7. PubMed ID: 25550871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TOX expression in cutaneous B-cell lymphomas.
    Schrader AM; Jansen PM; Willemze R
    Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
    Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
    Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD30 expression in cutaneous B-cell lymphomas.
    Afolayan-Oloye O; Zhao L; Tejasvi T; Chan MP; Harms PW; Fullen DR; Wilcox RA; Hristov AC
    J Cutan Pathol; 2023 Sep; 50(9):819-827. PubMed ID: 37290910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transformation of jejunoileal follicular lymphoma into diffuse large B-cell lymphoma detected using double-balloon enteroscopy.
    Nishimura T; Kuwai T; Imagawa H; Kohno H
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30021733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
    Aigner F; Korol D; Schmitt AM; Kurrer MO
    Histopathology; 2012 Apr; 60(5):774-84. PubMed ID: 22304695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on
    Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S
    Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse large B-cell lymphoma arising from follicular lymphoma with warthin's tumor of the parotid gland - immunophenotypic and genetic features: A case report.
    Wang CS; Chu X; Yang D; Ren L; Meng NL; Lv XX; Yun T; Cao YS
    World J Clin Cases; 2019 Nov; 7(22):3895-3903. PubMed ID: 31799320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 92-year-old man with primary cutaneous diffuse large B-cell non-Hodgkin's lymphoma manifesting as a giant scalp mass: A case report.
    Liao C; Yang M; Liu P; Zhang W
    Medicine (Baltimore); 2017 Mar; 96(10):e6270. PubMed ID: 28272240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
    Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
    Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
    G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
    de Oliveira Costa R; Hallack Neto A; Siqueira S; Lage LA; de Paula HM; Coutinho AM; Pereira J
    Nucl Med Commun; 2016 Oct; 37(10):1095-101. PubMed ID: 27281359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
    Yang H; Lang RG; Liu FF; Wang XF; Jin ZJ; Lü AJ; Wang Y; Fu XL; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):79-84. PubMed ID: 21426801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up.
    Kitabatake H; Nagaya T; Tanaka N; Ota H; Sano K; Asano N; Suga T; Nakamura Y; Akamatsu T; Tanaka E
    Clin J Gastroenterol; 2017 Feb; 10(1):79-85. PubMed ID: 27873064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma.
    Demirkesen C; Tüzüner N; Esen T; Lebe B; Ozkal S
    Leuk Res; 2011 Sep; 35(9):1269-72. PubMed ID: 21700336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
    Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
    Purroy N; Bergua J; Gallur L; Prieto J; Lopez LA; Sancho JM; García-Marco JA; Castellví J; Montes-Moreno S; Batlle A; de Villambrosia SG; Carnicero F; Ferrando-Lamana L; Piris MA; Lopez A
    Br J Haematol; 2015 Apr; 169(2):188-98. PubMed ID: 25521006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.